MyFinsight
Home
Blog
About
something is missing
$65,395K
Proceeds, issuance of
shares, share-based...
$86K
(-30.08%↓ Y/Y)
Proceeds from the
exercise of employee...
$32K
Net cash provided by
financing activities
$118K
(-99.82%↓ Y/Y)
Canceled cashflow
$65,395K
Net change in cash
and cash...
-$31,531K
(-260.53%↓ Y/Y)
Canceled cashflow
$118K
Stock-based compensation
$6,782K
(72.09%↑ Y/Y)
Accounts payable
$1,769K
(297.43%↑ Y/Y)
Non-cash lease expense
$209K
(93.52%↑ Y/Y)
Depreciation and
amortization
$34K
(-60.47%↓ Y/Y)
Proceeds from offering,
net of issuance...
-$60,661K
(-200.00%↓ Y/Y)
Proceeds from offering,
net of issuance...
-$4,734K
(-200.00%↓ Y/Y)
Net cash used in
operating activities
-$30,998K
(33.17%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$402K
(-167.91%↓ Y/Y)
Net cash used in
investing activities
-$249K
(-200.00%↓ Y/Y)
Canceled cashflow
$8,794K
Net loss
-$34,099K
(34.79%↑ Y/Y)
Purchases of property and
equipment
$249K
(200.00%↑ Y/Y)
Accrued expenses
-$4,526K
(-231.30%↓ Y/Y)
Other current assets
and prepaid...
$723K
(68.53%↑ Y/Y)
Other liabilities
-$236K
(-2.16%↓ Y/Y)
Operating lease liability
-$208K
(-76.27%↓ Y/Y)
Back
Back
Cash Flow
IMMUNIC, INC. (IMUX)
IMMUNIC, INC. (IMUX)
source: myfinsight.com